120 related articles for article (PubMed ID: 23826219)
1. Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.
Ligthart ST; Coumans FA; Bidard FC; Simkens LH; Punt CJ; de Groot MR; Attard G; de Bono JS; Pierga JY; Terstappen LW
PLoS One; 2013; 8(6):e67148. PubMed ID: 23826219
[TBL] [Abstract][Full Text] [Related]
2. Endothelium-Derived Extracellular Vesicles Associate with Poor Prognosis in Metastatic Colorectal Cancer.
Nanou A; Mol L; Coumans FAW; Koopman M; Punt CJA; Terstappen LWMM
Cells; 2020 Dec; 9(12):. PubMed ID: 33333805
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?
Bielčiková Z; Jakabová A; Pinkas M; Zemanová M; Kološtová K; Bobek V
Am J Transl Res; 2017; 9(6):2807-2823. PubMed ID: 28670371
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a cell line from human circulating colon cancer cells.
Cayrefourcq L; Mazard T; Joosse S; Solassol J; Ramos J; Assenat E; Schumacher U; Costes V; Maudelonde T; Pantel K; Alix-Panabières C
Cancer Res; 2015 Mar; 75(5):892-901. PubMed ID: 25592149
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
[TBL] [Abstract][Full Text] [Related]
6. KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer.
Kalikaki A; Politaki H; Souglakos J; Apostolaki S; Papadimitraki E; Georgoulia N; Tzardi M; Mavroudis D; Georgoulias V; Voutsina A
PLoS One; 2014; 9(8):e104902. PubMed ID: 25137394
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.
Das A; Kunkel M; Joudeh J; Dicker DT; Scicchitano A; Allen JE; Sarwani N; Yang Z; Kaifi J; Zhu J; Liao J; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):709-13. PubMed ID: 25806877
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
Mohamed Suhaimi NA; Foong YM; Lee DY; Phyo WM; Cima I; Lee EX; Goh WL; Lim WY; Chia KS; Kong SL; Gong M; Lim B; Hillmer AM; Koh PK; Ying JY; Tan MH
Mol Oncol; 2015 Apr; 9(4):850-60. PubMed ID: 25605225
[TBL] [Abstract][Full Text] [Related]
9. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Bidard FC; Peeters DJ; Fehm T; Nolé F; Gisbert-Criado R; Mavroudis D; Grisanti S; Generali D; Garcia-Saenz JA; Stebbing J; Caldas C; Gazzaniga P; Manso L; Zamarchi R; de Lascoiti AF; De Mattos-Arruda L; Ignatiadis M; Lebofsky R; van Laere SJ; Meier-Stiegen F; Sandri MT; Vidal-Martinez J; Politaki E; Consoli F; Bottini A; Diaz-Rubio E; Krell J; Dawson SJ; Raimondi C; Rutten A; Janni W; Munzone E; Carañana V; Agelaki S; Almici C; Dirix L; Solomayer EF; Zorzino L; Johannes H; Reis-Filho JS; Pantel K; Pierga JY; Michiels S
Lancet Oncol; 2014 Apr; 15(4):406-14. PubMed ID: 24636208
[TBL] [Abstract][Full Text] [Related]
10. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
11. Importance of circulating tumor cells in newly diagnosed colorectal cancer.
van Dalum G; Stam GJ; Scholten LF; Mastboom WJ; Vermes I; Tibbe AG; De Groot MR; Terstappen LW
Int J Oncol; 2015 Mar; 46(3):1361-8. PubMed ID: 25572133
[TBL] [Abstract][Full Text] [Related]
12. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.
De Mattos-Arruda L; Weigelt B; Cortes J; Won HH; Ng CKY; Nuciforo P; Bidard FC; Aura C; Saura C; Peg V; Piscuoglio S; Oliveira M; Smolders Y; Patel P; Norton L; Tabernero J; Berger MF; Seoane J; Reis-Filho JS
Ann Oncol; 2014 Sep; 25(9):1729-1735. PubMed ID: 25009010
[TBL] [Abstract][Full Text] [Related]
13. Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?
Turner N; Pestrin M; Galardi F; De Luca F; Malorni L; Di Leo A
Cancers (Basel); 2014 Mar; 6(2):684-707. PubMed ID: 24670368
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer.
Raimondi C; Nicolazzo C; Gradilone A; Giannini G; De Falco E; Chimenti I; Varriale E; Hauch S; Plappert L; Cortesi E; Gazzaniga P
Cancer Biol Ther; 2014 May; 15(5):496-503. PubMed ID: 24521660
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of circulating tumour cells-biology and biomarkers.
Krebs MG; Metcalf RL; Carter L; Brady G; Blackhall FH; Dive C
Nat Rev Clin Oncol; 2014 Mar; 11(3):129-44. PubMed ID: 24445517
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in colorectal cancer - a review of detection methods and clinical relevance.
Saadi S; Aarab M; Tabyaoui I; Jouti NT
Contemp Oncol (Pozn); 2023; 27(3):123-131. PubMed ID: 38239860
[TBL] [Abstract][Full Text] [Related]
18. The Utilization of Optically Induced Dielectrophoresis (ODEP)-Based Cell Manipulation in a Microfluidic System for the Purification and Sorting of Circulating Tumor Cells (CTCs) with Different Sizes.
Chu PY; Nguyen TNA; Wu AY; Huang PS; Huang KL; Liao CJ; Hsieh CH; Wu MH
Micromachines (Basel); 2023 Nov; 14(12):. PubMed ID: 38138338
[TBL] [Abstract][Full Text] [Related]
19. Improved Characterization of Circulating Tumor Cells and Cancer-Associated Fibroblasts in One-Tube Assay in Breast Cancer Patients Using Imaging Flow Cytometry.
Muchlińska A; Wenta R; Ścińska W; Markiewicz A; Suchodolska G; Senkus E; Żaczek AJ; Bednarz-Knoll N
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627197
[TBL] [Abstract][Full Text] [Related]
20. An Image-Based Identification of Aggressive Breast Cancer Circulating Tumor Cell Subtypes.
Kamal M; Wang YJ; Plummer S; Dickerson A; Yu M
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
